Sanofi | SNY - Ebit

Stock Price
48.36
Daily Change
0.91 1.92%
Monthly
1.90%
Yearly
-9.69%
Q1 Forecast
45.81

Sanofi reported EUR3.74B in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 1.45B 4.26B Sep/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Novartis USD 4.48B 343M Sep/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sanofi EUR 3.74B 2.23B Sep/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
UCB EUR 502M 168M Dec/2024
Zoetis USD 975M 40M Sep/2025